Amanta Healthcare Management Change
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Amanta Healthcare held its 31st Annual General Meeting on September 16, 2026, transacting ordinary and special business items via video conferencing.
Amanta Healthcare has commenced production at its new SteriPort facility at the Kheda campus. This brownfield expansion aims to improve operational efficiency and EBITDA margins.
Amanta Healthcare Ltd has provided a web-link for shareholders to access the Annual Report and Notice of the 31st Annual General Meeting.
Amanta Healthcare Limited has scheduled its 31st Annual General Meeting for September 16, 2026. Key agenda items include adopting financial statements and revising the Managing Director's remuneration.
Amanta Healthcare Limited has issued a notice for its 31st Annual General Meeting scheduled for September 16, 2026. Key agenda items include adopting financial statements and auditor appointments.
Amanta Healthcare Limited has released its Annual Report for FY 2025-26. The company will hold its 31st Annual General Meeting on September 16, 2026, via video conferencing.
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
Amanta Healthcare reported Q1FY27 revenue of Rs.68.8 Crore with EBITDA of Rs.15.2 Crore. Profitability was impacted by higher finance costs for new projects.
Amanta reported Q1FY27 revenue of INR 69 Cr (5% YoY) with 21% EBITDA margins. Strategy focuses on high-margin SteriPort/SVP capacity expansion and cost optimization via solar power.
Amanta Healthcare Limited submitted the Statement of Deviation in fund utilization for the quarter ended June 30, 2026, confirming no deviation in usage of IPO proceeds.
Amanta Healthcare Ltd reported revenue from operations of ₹68.8 Cr (+5.4% YoY) and net profit of ₹3.3 Cr (-5.7% YoY) for Q1 FY27.
Amanta Healthcare Ltd has appointed Mr. Nilesh Punjabi as Assistant Vice President (HR & Admin) and Senior Management Personnel, effective August 5, 2026.
Amanta Healthcare has scheduled a board meeting on August 5, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Amanta Healthcare Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI (LODR) Regulations.